Drugs / OVax
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00660101 | Jun 2008 → Dec 2015 | ovarian adenocarcinoma | AVAX Technologies | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OVax | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00660101 ↗ |
| Modality | Vaccine | “DNP-modified autologous ovarian tumor cell vaccine” NCT00660101 ↗ |